News story: New measures to avoid valproate exposure in pregnancy
Dr June Raine, Director of MHRA’s Vigilance and Risk Management of Medicines Division said: We welcome the CMDH endorsement of the strengthened regulatory position on valproate medicines which we have been championing through the Europe-wide review. Va… read more

